Leyden Labs raises $70 million: Novel class of broadly protective nasal sprays

Funding will propel Leyden Labs’ non-vaccine intranasal antibody programs to safeguard people from respiratory viruses

03-Feb-2025 - Leyden Laboratories B.V. announced it has raised $70M in funding to advance its Mucosal Protection Platform. This non-vaccine approach utilizes broadly protective intranasally administered antibodies to free people from the threat of respiratory viruses, such as influenza and coronaviruses. The ...

Merck to Acquire HUB Organoids Holding B.V.

Acquisition to advance company's cell culture portfolio with internationally recognized pioneer in organoid development

18-Dec-2024 - Merck has signed a definitive agreement with the intention to acquire HUB Organoids Holding B.V. (HUB). Organoids are cell culture models that functionally resemble an organ. They have the potential to speed up drug development, improve understanding of disease treatment in diverse populations, ...

Start-up aims to bring AI-powered protein engineering to every lab

Cradle raises $73M Series B: Speed up protein research and development by as much as ten times

03-Dec-2024 - Cradle, the leading platform for AI-powered protein engineering, has raised $73m in Series B funding to respond to rising demand for its technology in R&D intensive industries. The round was led by IVPwith participation from previous investors Index Ventures and Kindred Capital. With the current ...

QIAGEN collaborates with McGill University to advance microbiome research

15-Nov-2024 - QIAGEN announced a collaboration with the McGill University Centre for Microbiome Research to support microbiome research activities and outcomes. The three-year partnership will further drive microbiome sciences – the study of a community of microorganisms that can be found living together in ...

Collaboration between medac and start-up chiron to develop organ-on-chip technology

Further development and establishment of animal free testing methods for the pharmaceutical industry

12-Nov-2024 - Testing new substances in animals is a regulatory cornerstone of drug development. At the same time, the development of animal free testing methods is progressing. In this context the pharmaceutical company medac and the start-up chiron biotechnology are working together on the further ...

Ardena Expands Bioanalytical Services in Europe

01-Nov-2024 - Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, announced a substantial expansion of its Bioanalytical Services in the Netherlands. This strategic investment includes establishing a ...

Revealing DNA behavior in record time

26-Aug-2024 - “DNA, RNA and proteins are the key players to regulate all processes in the cells of our body,” Leiden Professor John van Noort explains. “To understand the (mis-)functioning of these molecules, it is essential to uncover how their 3D structure depends on their sequence and for this it is ...

UMC Utrecht and VectorY Therapeutics collaborate in ALS Biomarker Study

Finding these biomarkers is expected to help diagnose ALS and monitor disease progression and improve the design of future clinical studie

18-Jun-2024 - UMC Utrecht has enrolled its first patient for a new study to identify biomarkers of Amyotrophic Lateral Sclerosis (ALS). The observational investigator-initiated study is led by Professor Dr. Leonard van den Berg and supported by VectorY Therapeutics. VectorY Therapeutics is developing ...

Fungus breaks down ocean plastic

“What makes this research scientifically outstanding, is that we can quantify the degradation process”

17-Jun-2024 - A fungus living in the sea can break down the plastic polyethylene, provided it has first been exposed to UV radiation from sunlight. Researchers from, among others, NIOZ published their results in the scientific journal Science of the Total Environment. They expect that many more plastic ...

Portable AI-based test kit to identify bacterial infections

Dutch scientist selected as a finalist for the Young Inventors Prize 2024: Her startup focuses on the most common types of infection

11-Jun-2024 - According to a study published in The Lancet, one in eight global deaths in 2019 was caused by common bacterial infections, which are the second leading cause of death worldwide. Due to slow or ineffective diagnostics many treatments are carried out with limited information on the condition, ...